Abstract
An Artificial Intelligence-Based Program Significantly Reduces ESA (Erythropoiesis-Stimulating Agent) Use and Maintains Hemoglobin
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have